Cubist Systematic Strategies LLC Lowers Stake in Nu Skin Enterprises, Inc. $NUS

Key Points

• Cubist Systematic Strategies LLC reduced its stake in Nu Skin Enterprises by 16.6%, selling 98,690 shares in the first quarter, while still holding 494,101 shares valued at approximately $3.59 million.
• Several institutional investors, including Harbor Capital Advisors Inc. and GAMMA Investing LLC, significantly increased their holdings in Nu Skin Enterprises during the same period, indicating growing interest from the investment community.
• After reporting better-than-expected earnings for the last quarter, Nu Skin Enterprises announced a quarterly dividend of $0.06 per share, translating to a 2.0% yield.

Cubist Systematic Strategies LLC reduced its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 16.6% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 494,101 shares of the company's stock after selling 98,690 shares during the period. Cubist Systematic Strategies LLC owned approximately 0.99% of Nu Skin Enterprises worth $3,587,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Prescott Group Capital Management L.L.C. increased its position in Nu Skin Enterprises by 142.7% during the 1st quarter. Prescott Group Capital Management L.L.C. now owns 1,394,608 shares of the company's stock worth $10,125,000 after purchasing an additional 819,972 shares during the period. Pacer Advisors Inc. purchased a new stake in shares of Nu Skin Enterprises in the first quarter valued at approximately $4,577,000. Two Sigma Advisers LP boosted its stake in shares of Nu Skin Enterprises by 61.2% in the fourth quarter. Two Sigma Advisers LP now owns 944,000 shares of the company's stock valued at $6,504,000 after buying an additional 358,400 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Nu Skin Enterprises by 47.1% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,052,384 shares of the company's stock worth $7,640,000 after acquiring an additional 336,807 shares during the period. Finally, D. E. Shaw & Co. Inc. raised its position in Nu Skin Enterprises by 15.5% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 2,251,352 shares of the company's stock worth $15,512,000 after acquiring an additional 301,295 shares in the last quarter. Institutional investors and hedge funds own 82.84% of the company's stock.

Analyst Ratings Changes

NUS has been the subject of a number of recent analyst reports. Wall Street Zen downgraded Nu Skin Enterprises from a "strong-buy" rating to a "buy" rating in a report on Friday, September 5th. Zacks Research upgraded shares of Nu Skin Enterprises to a "hold" rating in a report on Tuesday, August 12th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $6.88.

Insider Activity at Nu Skin Enterprises

In other news, EVP Chayce David Clark sold 20,000 shares of the business's stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $11.97, for a total value of $239,400.00. Following the completion of the transaction, the executive vice president directly owned 233,140 shares of the company's stock, valued at $2,790,685.80. The trade was a 7.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Laura Nathanson sold 6,489 shares of the company's stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $12.22, for a total value of $79,295.58. Following the completion of the sale, the director owned 33,149 shares in the company, valued at $405,080.78. This represents a 16.37% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 58,926 shares of company stock valued at $711,364. 2.00% of the stock is owned by corporate insiders.

Nu Skin Enterprises Price Performance

Shares of NYSE:NUS traded down $0.09 during midday trading on Wednesday, hitting $11.52. 404,688 shares of the stock were exchanged, compared to its average volume of 543,236. Nu Skin Enterprises, Inc. has a twelve month low of $5.32 and a twelve month high of $12.40. The company has a current ratio of 2.01, a quick ratio of 1.38 and a debt-to-equity ratio of 0.27. The company has a 50 day moving average price of $10.13 and a 200-day moving average price of $8.24. The stock has a market cap of $569.99 million, a P/E ratio of 5.73 and a beta of 0.92.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.18. The firm had revenue of $386.14 million during the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. On average, research analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 10th. Investors of record on Friday, August 29th will be given a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Friday, August 29th. Nu Skin Enterprises's payout ratio is currently 11.94%.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.